Skip to main content
. 2022 Jun 12;27(12):3786. doi: 10.3390/molecules27123786

Table 1.

Virucidal activity of TTO against FCoVII and HCoV-OC43.

Formulation
(TTO%, EtOH%)
Time of
Exposure
(min)
FCoVII
(Log TCID50/mL)
HCoV-OC43
(Log RNA Copies/mL)
Virus
Exposed to TTO
Virus Control RV Virus
Inactivation (%)
Virus
Exposed to TTO
Virus Control RV Virus
Inactivation (%)
A *
(3.33, 5.33)
5 <0.50 4.00 ≥3.50 ≥99.97 * 2.58 3.36 0.78 83.41
15 <0.50 4.00 ≥3.50 ≥99.97 * 2.56 3.28 0.72 80.96
30 <0.50 4.00 ≥3.50 ≥99.97 * 2.78 4.16 1.38 95.83
B
(0.66, 1.06)
5 3.75 3.50 0.00 0.00 3.79 3.36 0.00 0.00
15 3.75 4.00 0.25 43.76 3.69 3.28 0.00 0.00
30 4.00 4.50 0.50 68.36 4.78 5.13 0.35 55.36
C
(0.13, 0.21)
5 3.50 3.50 0.00 0.00 3.24 3.36 0.00 0.00
15 4.00 4.00 0.00 0.00 3.45 3.28 0.00 0.00
30 4.50 4.50 0.00 0.00 4.80 5.13 0.33 53.28
D
(0.00, 5.33)
5 ND ND ND ND ND ND ND ND
15 ND ND ND ND ND ND ND ND
30 4.00 4.00 0.00 0.00 4.12 4.05 0.00 0.00
Disinfectant ** 5 <0.50 3.50 ≥3.00 ≥99.90 * 1.90 4.03 2.13 99.26

Reduction value (RV) is the reduction of the virus in test product (formulations A–D) compared to the virus control not exposed to the test product. The virus percentage inactivation is calculated using the formula 1 − (1/10RV) × 100%. * Due to cytotoxicity of the tested formulation A, the detection limit did not allow for the detection of higher FCoVII reduction. ** Disinfectant composition: isazone, benzalkonium chloride 50%, chlorhexidine gluconate, and isopropanol. ND = not determined.